All

What are you looking for?

All
Projects
Results
Organizations

Quick search

  • Projects supported by TA ČR
  • Excellent projects
  • Projects with the highest public support
  • Current projects

Smart search

  • That is how I find a specific +word
  • That is how I leave the -word out of the results
  • “That is how I can find the whole phrase”

Garcinol in gastrointestinal cancer prevention: recent advances and future prospects

The result's identifiers

  • Result code in IS VaVaI

    <a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F62156489%3A43210%2F24%3A43925505" target="_blank" >RIV/62156489:43210/24:43925505 - isvavai.cz</a>

  • Result on the web

    <a href="https://doi.org/10.1007/s00432-024-05880-6" target="_blank" >https://doi.org/10.1007/s00432-024-05880-6</a>

  • DOI - Digital Object Identifier

    <a href="http://dx.doi.org/10.1007/s00432-024-05880-6" target="_blank" >10.1007/s00432-024-05880-6</a>

Alternative languages

  • Result language

    angličtina

  • Original language name

    Garcinol in gastrointestinal cancer prevention: recent advances and future prospects

  • Original language description

    Gastrointestinal cancers continue to pose a significant global health challenge, with millions of new cases diagnosed each year. Despite advancements in treatment, the prognosis for many patients remains poor. This article explores the potential of garcinol, a polyisoprenylated benzophenone found in various Garcinia species, as a therapeutic agent against gastrointestinal malignancies. The objective is to review recent research on garcinol&apos;s anticancer properties, its mechanisms of action, and safety aspects. Garcinol exhibits anticancer effects in esophageal, gastric, colorectal, pancreatic, and liver cancers by inhibiting metastasis, inducing apoptosis, and targeting key molecular pathways in cancer progression. Nanotechnology is explored as a means to enhance garcinol delivery and efficacy. Safety assessments suggest a promising toxicity profile. Garcinol shows significant potential as a natural therapeutic agent for gastrointestinal cancers, and future research is needed on optimizing its delivery, exploring synergistic combinations, and conducting clinical trials to validate its efficacy and safety for clinical applications.

  • Czech name

  • Czech description

Classification

  • Type

    J<sub>imp</sub> - Article in a specialist periodical, which is included in the Web of Science database

  • CEP classification

  • OECD FORD branch

    30402 - Technologies involving the manipulation of cells, tissues, organs or the whole organism (assisted reproduction)

Result continuities

  • Project

  • Continuities

    I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace

Others

  • Publication year

    2024

  • Confidentiality

    S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Data specific for result type

  • Name of the periodical

    Journal of Cancer Research and Clinical Oncology

  • ISSN

    0171-5216

  • e-ISSN

    1432-1335

  • Volume of the periodical

    150

  • Issue of the periodical within the volume

    7

  • Country of publishing house

    DE - GERMANY

  • Number of pages

    11

  • Pages from-to

    370

  • UT code for WoS article

    001281175200004

  • EID of the result in the Scopus database

    2-s2.0-85199882784